Eric Dane, ‘Grey’s Anatomy’ Heartthrob and ALS Advocate, Dies at 53

Eric Dane, the actor who gained nationwide recognition for his function as Dr. Mark “McSteamy” Sloan on the long-running TV sequence Gray’s AnatomyHe handed away 10 months after saying that he had been identified with ALS (amyotrophic lateral sclerosis), also referred to as Lou Gehrig’s illness. He was 53 years outdated.

“He spent his remaining days surrounded by his expensive pals, his devoted spouse, and his two stunning daughters, Billie and Georgia, who had been the middle of his world,” his household mentioned in an announcement.

Dane was married to actor Rebecca Gayheart. The 2 separated in 2018, however she supported him all through his sickness.

Dane additionally appeared within the HBO drama euphoria As Cal Jacobs, he introduced his prognosis in April 2025. By June of that yr, he mentioned he might now not use his proper arm. However that hasn’t stopped him from utilizing his superstar to lift consciousness for ALS, a uncommon illness that at present has no remedy.

“By way of his battle with ALS, Eric turned a passionate advocate for consciousness and analysis, decided to make a distinction for others going through the identical battle,” the household assertion mentioned. “He might be enormously missed and can all the time be fondly remembered. Eric cherished his followers and is perpetually grateful for the outpouring of affection and assist he obtained.”

What’s ALS?

Amyotrophic lateral sclerosis is a uncommon degenerative illness that targets nerves within the mind and spinal twine, resulting in lack of muscle management.

Legendary New York Yankees baseball participant Lou Gehrig was identified with ALS in 1939 on the age of 36. He died two years later.

In ALS, muscular tissues progressively atrophy or weaken. This worsens motion issues and impairs the flexibility to stroll, use arms and arms, converse, chew, and swallow. Affecting the flexibility to breathe might be life-threatening.

There isn’t a remedy for ALS, however medicines and different therapies can sluggish development and lengthen independence. In america, ALS sufferers have a median life expectancy of three to five years after prognosis.